VCO, lagundi, tawa-tawa no substitute for COVID-19 vaccines - experts | ABS-CBN
ADVERTISEMENT
![dpo-dps-seal](https://od2-image-api.abs-cbn.com/prod/Seal_Image_OD.png)
Welcome, Kapamilya! We use cookies to improve your browsing experience. Continuing to use this site means you agree to our use of cookies. Tell me more!
VCO, lagundi, tawa-tawa no substitute for COVID-19 vaccines - experts
VCO, lagundi, tawa-tawa no substitute for COVID-19 vaccines - experts
Jasmin Romero,
ABS-CBN News
Published Nov 17, 2021 03:33 PM PHT
![Clipboard](https://od2-image-api.abs-cbn.com/prod/ClipboardNews.png)
MANILA — Despite the noted health benefits of virgin coconut oil, tawa-tawa and lagundi, these are still "no substitute" for COVID-19 vaccines, according to scientists doing in-depth studies on the efficacy of the organic products against the respiratory disease.
MANILA — Despite the noted health benefits of virgin coconut oil, tawa-tawa and lagundi, these are still "no substitute" for COVID-19 vaccines, according to scientists doing in-depth studies on the efficacy of the organic products against the respiratory disease.
“Lagundi will not replace your vaccination. Please lang, do not use it to prevent COVID-19 and say 'di na ako magpapabakuna (I will not get the vaccine),” Dr. Cecilia Maramba-Lazarte, UP Manila’s Director for the Institute of Herbal Medicine, said in an online forum.
“Lagundi will not replace your vaccination. Please lang, do not use it to prevent COVID-19 and say 'di na ako magpapabakuna (I will not get the vaccine),” Dr. Cecilia Maramba-Lazarte, UP Manila’s Director for the Institute of Herbal Medicine, said in an online forum.
Other scientists—Dr. Imelda Angeles-Agdeppa, director of Department of Science and Technology–Food and Nutrition Research Institute, and Dr. Philip Ian Padilla, UP Visayas Vice Chancellor for Academic Affairs—also made the same call.
Other scientists—Dr. Imelda Angeles-Agdeppa, director of Department of Science and Technology–Food and Nutrition Research Institute, and Dr. Philip Ian Padilla, UP Visayas Vice Chancellor for Academic Affairs—also made the same call.
Agdeppa and Padilla are conducting studies on VCO and tawa-tawa, respectively.
Agdeppa and Padilla are conducting studies on VCO and tawa-tawa, respectively.
ADVERTISEMENT
“Whether tawa-tawa is going to be effective or that significant for COVID-19, I still cannot say. We have to wait for the data we are crunching right now,” Padilla said.
“Whether tawa-tawa is going to be effective or that significant for COVID-19, I still cannot say. We have to wait for the data we are crunching right now,” Padilla said.
Agdeppa emphasized that the public should consult their doctors before using VCO.
Agdeppa emphasized that the public should consult their doctors before using VCO.
“I still cannot recommend it because if you have history of other illness, you still need the advise of your doctor,” she said in a mix of Filipino and English.
“I still cannot recommend it because if you have history of other illness, you still need the advise of your doctor,” she said in a mix of Filipino and English.
Based on the latest results of their studies, it was concluded that lagundi “can be safely used for the symptomatic treatment of mild COVID” disease.
Based on the latest results of their studies, it was concluded that lagundi “can be safely used for the symptomatic treatment of mild COVID” disease.
Meanwhile, VCO could be used as an adjunct supplement for suspect and probable cases of COVID 19.
Meanwhile, VCO could be used as an adjunct supplement for suspect and probable cases of COVID 19.
Data on tawa-tawa research is still being analyzed.
Data on tawa-tawa research is still being analyzed.
To date, the Philippines has fully immunized more than 32.2 million people or 41.76 percent of the government's target.
To date, the Philippines has fully immunized more than 32.2 million people or 41.76 percent of the government's target.
[BOLD] RELATED VIDEO
Read More:
VCO
lagundi
tawa-tawa
COVID-19 vaccines
COVID-19
COVID19
coronavirus
Dr. Cecilia Maramba-Lazarte
Dr. Imelda Angeles-Agdeppa
Dr. Philip Ian Padilla
ADVERTISEMENT
ADVERTISEMENT